Home
NewsNewsLG Chem’s App for Infertility and Pregnancy Preparation, Bloom, brings together fertility education, treatment explanations, emotional support, and preparation tools in one digital platform. Designed as a companion rather than a clinical service, the app addresses growing information gaps faced by individuals and couples navigating infertility and pregnancy preparation.
Infertility has become a significant concern in modern society, with delayed marriages, environmental factors, and lifestyle changes contributing to increased fertility challenges. As more individuals and couples seek support during pregnancy preparation, digital healthcare tools are emerging to bridge the information gap. One such platform is the Bloom app for infertility and pregnancy preparation, developed by LG Chem in collaboration with leading reproductive medicine organizations in Korea.
Unveiled in September 2025, Bloom isn’t just another health app. It is a digital healthcare platform designed to give people scientifically grounded guidance on fertility, infertility, and preparing the body and mind for pregnancy. LG Chem positioned Bloom as a companion for women aiming to conceive, couples facing difficulties conceiving, and individuals looking toward future fertility preservation. The app’s name carries metaphorical weight: a blend of new life, hope, and the full bloom of possibility.
Infertility is no longer a fringe issue. Demographic shifts, like later marriages and changing lifestyles, mean that increasing numbers of couples confront conception challenges. But beyond statistics, the emotional landscape can be heavy: confusion, countless online searches, and uncertainty about what steps to take next. LG Chem’s internal research suggested that while information exists, it’s scattered, technical, and often hard for laypeople to parse. Bloom aims to centralize that information and make it usable.
The Bloom app for infertility and pregnancy preparation includes several informational and support components:
A few months after its release, Bloom gained industry validation. In December 2025, the app won the grand prize in the medical service category at the Smart App Awards, one of Korea’s respected tech recognitions, judged by a 4,000-member panel assessing design, user interface, content quality, and technological innovation.
The award citation emphasized Bloom’s scientific approach to supporting both infertility and pregnancy preparation, acknowledging that these are not purely personal concerns but broader public health issues. Such recognition suggests that the app’s design aligns with real-world needs, not just corporate ambition.
While the Bloom app for infertility and pregnancy preparation serves as a comprehensive information resource, it functions as a supplementary tool to professional medical consultation. The app provides educational content and practical guidance but does not replace individualized medical advice from fertility specialists or reproductive endocrinologists.
The Bloom app for infertility and pregnancy preparation represents an effort to consolidate infertility-related information, emotional support resources, and practical preparation materials into a single digital platform. By providing expert-verified content and community features, the Bloom app for infertility and pregnancy preparation addresses some of the informational and emotional needs individuals and couples face during pregnancy preparation and infertility treatment journeys.
Luna and Kindbody are redefining Intelligence in Fertility Care through a strategic partnership that integrates wearable biomarker tracking into clinical pathways. By capturing real-time physiological data, the collaboration enables personalised insights, enhances decision-making, and creates a more connected, data-driven fertility journey for patients and care providers alike.
Sapyen and Avenues launch at-home fertility diagnostics, introducing a couple-first testing model in the UK. By integrating semen analysis and AMH testing into early care, this approach reduces clinic visits, accelerates diagnosis, and ensures balanced fertility evaluation, transforming how patients begin their reproductive health journey.
Nexpring Health has invested in May Health to accelerate the development of the Anavi™ System, a novel device designed to treat PCOS-Related Infertility. The technology aims to restore ovulation through a single office-based procedure, expanding treatment options for millions of women affected by polycystic ovary syndrome.
INVO Fertility would be introducing time-lapse incubation technology at its Wisconsin clinic, hence offering high-quality lab care, creative patient solutions, and advanced embryo monitoring for improved fertility results.
Costco, Sesame, and IVI RMA North America have announced strategic partnership to alter fertility care in the U.S. by removing biggest obstacles to care including high costs and limited access.
Carea has launched its Trying to Conceive - IVF/IUI mode to help women undergoing intricate fertility treatment with risks of inconsistent clinic continuity through continuous tracking and expert guidance.
The Minnesota bill for infertility treatments mandates comprehensive insurance coverage for diagnosis, IVF, and fertility preservation across public and private health plans. Set for implementation in 2027, the legislation expands access, modernises infertility definitions, and ensures cost-sharing protections to make reproductive healthcare more equitable.
